rs8684

Variant names:

• chr15-66491272-G-A
• rs8684
• NM_002755.4:c.*657G>A

Your query was ambiguous. Multiple possible variants found:

• chr15-66491272-G-A
• chr15-66491272-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_002755.4(MAP2K1):​c.*657G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0599 in 237,318 control chromosomes in the GnomAD database, including 586 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency:
  • Genomes: 𝑓 0.056 (343 hom., cov: 32)
  • Exomes 𝑓: 0.067 (243 hom.)
• Consequence: MAP2K1 NM_002755.4 3_prime_UTR
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 0.848
• Publications: 12 publications found

Genes affected

MAP2K1 (HGNC:6840): (mitogen-activated protein kinase kinase 1) The protein encoded by this gene is a member of the dual specificity protein kinase family, which acts as a mitogen-activated protein (MAP) kinase kinase. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This protein kinase lies upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon wide variety of extra- and intracellular signals. As an essential component of MAP kinase signal transduction pathway, this kinase is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development. [provided by RefSeq, Jul 2008]

ENSG00000261351 (HGNC:):

SNAPC5 (HGNC:15484): (small nuclear RNA activating complex polypeptide 5) This gene encodes a subunit of the small nuclear RNA (snRNA)-activating protein complex that plays a role in the transcription of snRNA genes. This complex binds to the promoters of snRNA genes transcribed by either RNA polymerase II or III and recruits other regulatory factors to activate snRNA gene transcription. The encoded protein may play a role in stabilizing this complex. A pseudogene of this gene has been identified on chromosome 6. [provided by RefSeq, Jul 2016]

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.58).
• BA1: GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0775 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002755.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	MAP2K1	NM_002755.4	MANE Select	c.*657G>A		3_prime_UTR	Exon 11 of 11	NP_002746.1	Q02750-1
	MAP2K1	NM_001411065.1		c.*657G>A		3_prime_UTR	Exon 10 of 10	NP_001397994.1	A0A8I5KYS7
	SNAPC5	NM_006049.4		c.*22-555C>T		intron	N/A	NP_006040.1	O75971-1

Ensembl Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	MAP2K1	ENST00000307102.10	TSL:1 MANE Select	c.*657G>A		3_prime_UTR	Exon 11 of 11	ENSP00000302486.5	Q02750-1
	ENSG00000261351	ENST00000565387.2	TSL:1	n.109-555C>T		intron	N/A
	MAP2K1	ENST00000685172.1		c.*539G>A		3_prime_UTR	Exon 10 of 10	ENSP00000509604.1	A0A8I5KYB4

Frequencies

GnomAD3 genomes AF: 0.0563 AC: 8556 AN: 152052 Hom.: 342 Cov.: 32

Gnomad AFR AF: 0.0222

Gnomad AMI AF: 0.0901

Gnomad AMR AF: 0.0443

Gnomad ASJ AF: 0.0931

Gnomad EAS AF: 0.000578

Gnomad SAS AF: 0.0286

Gnomad FIN AF: 0.0802

Gnomad MID AF: 0.114

Gnomad NFE AF: 0.0793

Gnomad OTH AF: 0.0652

GnomAD4 exome AF: 0.0665 AC: 5665 AN: 85148 Hom.: 243 Cov.: 0 AF XY: 0.0671 AC XY: 2654 AN XY: 39574

African (AFR) AF: 0.0206 AC: 80 AN: 3878

American (AMR) AF: 0.0391 AC: 138 AN: 3532

Ashkenazi Jewish (ASJ) AF: 0.103 AC: 524 AN: 5110

East Asian (EAS) AF: 0.00 AC: 0 AN: 11314

South Asian (SAS) AF: 0.0229 AC: 28 AN: 1222

European-Finnish (FIN) AF: 0.0785 AC: 41 AN: 522

Middle Eastern (MID) AF: 0.102 AC: 50 AN: 492

European-Non Finnish (NFE) AF: 0.0818 AC: 4269 AN: 52170

Other (OTH) AF: 0.0774 AC: 535 AN: 6908

GnomAD4 genome AF: 0.0562 AC: 8556 AN: 152170 Hom.: 343 Cov.: 32 AF XY: 0.0561 AC XY: 4172 AN XY: 74402

African (AFR) AF: 0.0222 AC: 921 AN: 41502

American (AMR) AF: 0.0442 AC: 676 AN: 15290

Ashkenazi Jewish (ASJ) AF: 0.0931 AC: 323 AN: 3470

East Asian (EAS) AF: 0.000579 AC: 3 AN: 5182

South Asian (SAS) AF: 0.0293 AC: 141 AN: 4818

European-Finnish (FIN) AF: 0.0802 AC: 849 AN: 10586

Middle Eastern (MID) AF: 0.109 AC: 32 AN: 294

European-Non Finnish (NFE) AF: 0.0793 AC: 5393 AN: 68010

Other (OTH) AF: 0.0645 AC: 136 AN: 2108

Alfa AF: 0.0754 Hom.: 565

Bravo AF: 0.0521

Asia WGS AF: 0.0210 AC: 73 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.58
CADD	Benign	0.94
DANN	Benign	0.51
PhyloP100		0.85
RBP_binding_hub_radar		0.0
RBP_regulation_power_radar		1.1
Mutation Taster		=98/2	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs8684; hg19: chr15-66783610;